Good morning, you're tuned in to Markets Desk.
Novo Nordisk is extending its Wegovy footprint into Asia, with Japan clearing the weight loss drug for use in patients with metabolic dysfunction-associated steatohepatitis, known as MASH. That's a significant liver disease indication, and the first of its kind in Japan, with Sumitomo Pharma co-promoting the treatment domestically. Investors will be watching closely to see how quickly that market ramps.
Shifting to the space economy, Elon Musk is projecting SpaceX will hit one trillion dollars in revenue by two thousand thirty, a figure that would make it one of the largest companies on earth. But analysts are pointing to at least one artificial intelligence name that could reach that threshold first, underscoring just how fast the AI revenue story is compressing timelines that once seemed extraordinary.
And in diplomatic news, Italy's Foreign Minister has canceled a planned visit to the United States after President Trump reportedly claimed that Prime Minister Giorgia Meloni, quote, begged for a photo with him at the G-seven summit in France. Rome pushed back sharply, calling the characterization false, and the cancellation signals real friction between two administrations that had otherwise maintained relatively warm ties.
That's the tape. Markets Desk, signing off the floor.
